Creative Medical Technology Holdings (CELZ) Net Equity Issued and Repurchased (2016 - 2026)

Creative Medical Technology Holdings (CELZ) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $3.4 million the latest figure, recorded in Q1 2025.

• In Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $18.8 million (changed 0.0% YoY), while the FY2025 annual figure was $7.2 million, up 340.3% from the prior year.
• Net Equity Issued and Repurchased slipped to $3.4 million in Q1 2025 per CELZ's latest filing, from $15.5 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $15.5 million in Q3 2022 and bottomed at -$462000.0 in Q3 2021.
• Historically, Net Equity Issued and Repurchased has averaged $6.7 million across 3 years, with a median of $3.4 million in 2025.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 3448.87% in 2022 and fell as far as 3448.87% in 2022.
• Creative Medical Technology Holdings' Net Equity Issued and Repurchased stood at $14.8 million in 2021, then increased by 4.83% to $15.5 million in 2022, then tumbled by 78.26% to $3.4 million in 2025.
• Business Quant data shows CELZ's Net Equity Issued and Repurchased at $3.4 million in Q1 2025, $15.5 million in Q3 2022, and $14.8 million in Q4 2021.